Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System

• Elizabeth A. ChrischillesUniversity of Iowa
• Joshua J. GagneBrigham and Women's Hospital
• BRUCE H. FIREMANKaiser Permanente
• Jennifer C. NelsonKaiser Permanente Washington Health Research Institute
• Sengwee TohHarvard University
• Azadeh ShoaibiCenter for Biologics Evaluation and Research
• Marsha E. ReichmanUnited States Food and Drug Administration
• Shirley V. WangBrigham and Women's Hospital
• Michael NguyenUnited States Food and Drug Administration
• Rongmei ZhangUnited States Food and Drug Administration
• Rima IzemUnited States Food and Drug Administration
• Margie R. GouldingUnited States Food and Drug Administration
• Mary Ross SouthworthUnited States Food and Drug Administration
• David J. GrahamUnited States Food and Drug Administration
• Candace C. FullerHarvard University
• Hannah KatcoffHarvard University
• Tiffany Siu WoodworthHarvard University
• Catherine RogersHarvard University
• Ryan SaligaHarvard University
• Nancy D. Lin
• Cheryl N. McMahill‐WalravenAetna (United States)
• Vinit P. NairHumana (United States)
• Kevin HaynesCarelon Research (United States)
• Ryan M. CarnahanUniversity of Iowa